TEG system is designed to produce timely, reliable results from any operator in any location

Scroll to Explore

Clinical Value

Scientific literature shows that the use of TEG technology can help clinicians to improve patient outcomes and reduce costs by analyzing the coagulation state of a blood sample (11-12). By individualizing goal-directed coagulation management, it is possible to reduce inappropriate blood transfusions (7-9), and stratify patients according to their risk of bleeding and/or thrombotic complications (3, 10, 13-15). There is consequently a great opportunity to achieve substantial cost savings with a goal-directed TEG program (10-11).


Blood Product Use

The overall goal of the TEG® system is to reduce the use of unnecessary blood products and reduce thrombotic complications leading to improved patient outcomes.

Using the TEG system to monitor a patient’s hemostasis during surgery allows for a reduction in blood product usage by providing clinicians with information to help determine which specific blood products are needed to stop bleeding, and accurately identifies the need for re-operations by ruling out a coagulopathic cause of bleeding (7-12).


Platelet Function

Identifying inhibitions in platelet function can provide important information to help the clinician assess bleeding and ischemic events.

Anticoagulant or antiplatelet therapy is often stopped a few days before cardiovascular surgery to reduce the risk of perioperative bleeding while potentially increasing the risk of a thromboembolic event in the preoperative period.

TEG® PlateletMapping® assays can be used to assess platelet function and inhibition post-operatively or after percutaneous coronary intervention (PCI) (6, 10, 13-15).


of the Risk of Thrombosis

The ability to test and evaluate platelet function is an important factor in deciding if a patient is at risk of platelet-related thrombosis or hemorrhage. Studies have demonstrated an association between TEG® system results and ischemic events or thrombotic complications in cardiac surgery and interventional cardiology (6, 13-15). Furthermore, TEG system tests are sensitive to hypercoagulable states which may be predictive of thromboembolic events (16).